Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group

Luebbert, Michael; Suciu, Stefan; Hagemeijer, Anne; Rueter, Bjoern; Platzbecker, Uwe; Giagounidis, Aristoteles; Selleslag, Dominik; Labar, Boris; Germing, Ulrich; Salih, Helmut R.; Muus, Petra; Pflueger, Karl-Heinz; Schaefer, Hans-Eckart; Bogatyreva, Lioudmila; Aul, Carlo; de Witte, Theo; Ganser, Arnold; Becker, Heiko; Huls, Gerwin; van der Helm, Lieke; Vellenga, Edo; Baron, Frederic; Marie, Jean-Pierre; Wijermans, Pierre W.

Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group

Autor(en):

Luebbert, Michael; Suciu, Stefan; Hagemeijer, Anne; Rueter, Bjoern; Platzbecker, Uwe; Giagounidis, Aristoteles; Selleslag, Dominik; Labar, Boris; Germing, Ulrich; Salih, Helmut R.; Muus, Petra; Pflueger, Karl-Heinz; Schaefer, Hans-Eckart; Bogatyreva, Lioudmila; Aul, Carlo; de Witte, Theo; Ganser, Arnold; Becker, Heiko; Huls, Gerwin; van der Helm, Lieke; Vellenga, Edo; Baron, Frederic; Marie, Jean-Pierre; Wijermans, Pierre W.

Tübinger Autor(en):

Salih, Helmut R.

Erschienen in:

Annals of Hematology (2016), Bd. 95, H. 2, S. 191-199

Verlagsangabe:

Springer

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1007/s00277-015-2547-0

ISSN:

1432-0584